UiPath (NYSE:PATH) shares staged a modest recovery in Monday's premarket session, gaining 1.7% to $11.02, as investors shifted their attention to the company's share buyback program following a sharp decline triggered by broader AI sector weakness. The stock had fallen 10.8% last week, closing Friday at $10.84, a level 5.5% below the average price UiPath paid for its share repurchases in the first fiscal quarter.
The company acquired 20.4 million shares at an average price of $11.47 during fiscal Q1, spending $243.8 million on buybacks—equivalent to 1.85 times its operating cash flow. In March, the board authorized an additional $500 million for repurchases, signaling confidence in the company's long-term value. However, the current stock price now trades below that cost, raising questions about future capital allocation decisions.
Competitive Pressures from OpenAI
The steepest decline came on Wednesday, when UiPath shares slid 11.1% following news that OpenAI is developing a product called Presence, a control layer for enterprise agents that links AI models to organizational data, policies, and workflows. This directly competes with UiPath's expanding enterprise workflow automation platform, which is increasingly focused on agentic AI solutions.
UiPath's decline was significantly steeper than that of its workflow software peers. ServiceNow (NYSE:NOW) fell just 4.3% over the same period, while Salesforce (NYSE:CRM) dropped 4.2%. The 6.5 percentage point underperformance suggests investors perceive UiPath as facing greater substitution risk from OpenAI's offering.
ARR Growth Shows Signs of Deceleration
UiPath's fiscal first-quarter results, reported in May, showed annual recurring revenue (ARR) of $1.901 billion, up 12% year-over-year. However, the company's guidance for fiscal Q2 projects ARR between $1.929 billion and $1.934 billion, implying a sequential increase of just $28 million to $33 million—a slowdown from the $49 million in net new ARR added in Q1.
CEO Daniel Dines previously stated that the company's agentic products are "moving from pilot to production," but the deceleration in ARR growth has become a key metric for investors. The fiscal quarter ends on Friday, July 31, and no investor events are planned for this week.
Heavy Trading Volume and Short Interest
Trading activity was unusually intense last week, with nearly 564 million PATH shares changing hands—approximately 1.4 times the company's reported public float. As of July 15, short interest stood at 28.9% of float, a level that likely amplified Wednesday's sell-off and may have contributed to Friday's 6.3% bounce.
UiPath's capital allocation strategy remains under scrutiny. The company spent an additional $149.4 million on acquisition payments during the quarter, further reducing cash reserves. While buybacks can support per-share metrics, they also consume cash that could be used for strategic investments or to weather competitive threats.
Risks and Outlook
Key risks include potential delays in customer renewals or pricing pressure from OpenAI and other major software platforms. A soft quarter-end ARR outcome could lead to downward estimate revisions. While larger buybacks may boost earnings per share in the short term, they also reduce financial flexibility.
Investors will be watching closely for any signs of whether UiPath will continue repurchasing shares at current levels, and how ARR growth trends in the coming quarters. The immediate test is clear: can UiPath maintain its momentum in the face of intensifying competition from AI giants?
